Targeting of the MYC paralog-PARP1-DDR signaling pathway using the combination of BETi JQ1 and PARPi BMN673 demonstrated excellent anti-tumor efficacy in MYC paralog-dependent SCLC cells. The gene discussed is MYC; the disease is neoplasm.